Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.040 | 5 | 149817119 | intron variant | T/G | snv | 0.42 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.040 | 5 | 149817119 | intron variant | T/G | snv | 0.42 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.040 | 5 | 149817119 | intron variant | T/G | snv | 0.42 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
5 | 149800331 | intron variant | A/C | snv | 3.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
5 | 149800331 | intron variant | A/C | snv | 3.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.851 | 0.080 | 5 | 149816671 | intron variant | G/C | snv | 0.36 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.080 | 5 | 149816671 | intron variant | G/C | snv | 0.36 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.080 | 5 | 149816671 | intron variant | G/C | snv | 0.36 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.851 | 0.080 | 5 | 149816671 | intron variant | G/C | snv | 0.36 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.080 | 5 | 149816671 | intron variant | G/C | snv | 0.36 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 5 | 149814922 | intron variant | C/T | snv | 0.33 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
5 | 149762504 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
0.851 | 0.200 | 5 | 149832680 | missense variant | G/C | snv | 9.4E-02 | 0.11 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 0.500 | 2 | 2006 | 2016 | ||||||
|
0.851 | 0.200 | 5 | 149832680 | missense variant | G/C | snv | 9.4E-02 | 0.11 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 0.500 | 2 | 2006 | 2016 | ||||||
|
0.851 | 0.160 | 5 | 149732603 | intron variant | A/G | snv | 0.47 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.160 | 5 | 149732603 | intron variant | A/G | snv | 0.47 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.160 | 5 | 149732603 | intron variant | A/G | snv | 0.47 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.160 | 5 | 149732603 | intron variant | A/G | snv | 0.47 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.080 | 5 | 149832947 | missense variant | C/A;G;T | snv | 5.1E-02; 8.0E-06; 2.8E-05 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.882 | 0.160 | 5 | 149832908 | missense variant | G/A | snv | 8.5E-02 | 6.9E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.882 | 0.160 | 5 | 149832908 | missense variant | G/A | snv | 8.5E-02 | 6.9E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.882 | 0.160 | 5 | 149832908 | missense variant | G/A | snv | 8.5E-02 | 6.9E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
1.000 | 0.080 | 5 | 149825854 | intron variant | C/A | snv | 0.22 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.080 | 5 | 149832867 | missense variant | G/A | snv | 8.3E-02 | 4.7E-02 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.925 | 0.080 | 5 | 149731403 | intron variant | A/C | snv | 0.14 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 |